BioPharma Credit PLC (BPCR.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.04B |
| Enterprise Value | 1.03B |
| P/E Ratio | 10.2 |
| PEG Ratio | -0.76 |
| Price/Sales Ratio | 9.05 |
| Price/Book Ratio | 0.96 |
| Enterprise/Revenue | 8.48 |
| Enterprise/EBITDA | 17.9 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.89 |
| Operating Margin | 0.89 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 140.23M |
| Revenue/Share | 0.11 |
| Gross Profit | 114.5M |
| EBITDA | 129.89M |
| Net Income | 129.89M |
| Diluted EPS | 0.11 |
Balance Sheet
| Total Cash | 68.71M |
| Total Cash/Share | 0.06 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 26.43 |
| Book Value Per Share | 1.01 |
Price History
| 52-Week Change | 5.65 |
| 52-Week High | 1 |
| 52-Week Low | 0.88 |
| Moving Average 50 Days | 0.97 |
| Moving Average 200 Days | 0.95 |
Statistics
| Average Volume | 1.43M |
| Shares Outstanding | 1.12B |
| % Held by Institutions | 0.26 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.08 |
| Trailing Annual Dividend Yield | 8.69 |
| Payout Ratio | 1.04 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
